On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Besponsa is a targeted therapy that is thought to work by binding to B-cell ALL cancer cells that express the CD22 antigen, blocking the growth of cancerous cells. Continue reading
A study in MCN notes that most nurses who care for women during the postpartum period aren’t current on the rates and timing of maternal mortality during the postpartum period; 88% didn’t identify the leading three causes of maternal mortality. In addition, on the day of discharge, more than two thirds of RNs (67%) spend less than 10 minutes of time teaching mothers about warning signs of potential complications. Continue reading
A randomized, double-blind, placebo-controlled trial reported in Nature notes that combining a probiotic with fructo-oligosaccharide significantly reduces sepsis and mortality in newborns in rural India at a cost of $1 per infant. Continue reading
A Higher Degree of Education!
Aspen University has always been an online University- effectively leading the way in online education. By reaching the learner in his or her real world, and real work environment, distance learning programs enhance the way individuals learn best: through experience, reflection, implementation and experiment. By stepping out of the known environment of classroom-centered instruction, Aspen University’s distance learning programs consider what needs to be gained or changed through the learning process. Aspen’s programs provide its graduates with an advantage to excel in the challenging professional work environments of today and tomorrow. Continue reading
There are so many opportunities in the nursing field that can move your career in unexpected ways and into different places. Here are some examples of nursing specialties that you may not be aware of.
In 1986, Annie Lehy became a nurse. Little did she know that her profession could take on so many different roles. As she faced different obstacles and opportunities, she has been able to use her nursing degree in a number of non-traditional ways. So far, she’s been a successful writer and writing facilitator; trainer in areas of risk assessment and interventions; consultant motivational coach and counselor; and even a psychotherapist. Continue reading
There was a time when Chenai Mathabire read Vogue, watched beauty pageants on TV and fantasized about being a supermodel. Today she helps the sick and injured as a nurse and epidemiologist.
Last month, the 35-year-old Zimbabwean received an International AIDS Society prize for showing that a faster tuberculosis test could be implemented at health centers in southeast Africa. Her work will help save the lives of HIV-positive patients who contract TB.
“Nursing is often looked down upon and people just think you are there to be the maid of the doctor or do the dirty work. But teachers made me realize that nurses have a big role to play,” says Mathabire. Continue reading
Aspen University offers an online RN to BSN degree program for registered nurses who have an associate degree or diploma in nursing and wish to pursue a baccalaureate degree.
With a liberal arts foundation, our RN-to-BSN program builds on initial nursing preparation to prepare nurses for a broader scope of practice with a useful understanding of the cultural, political, economic, and social issues that affect patients and influence care delivery. It is designed for adult learners wishing to complete their undergraduate degree without the on-campus class requirement. Continue reading
Scientists have found that a dangerous bacterium capable of causing serious gut infections is triggered by excess calcium in its environment, but the triggering factor might also provide the solution.
Clostridium difficile is a bacterium that chiefly affects older patients living in nursing homes, or those who have been confined to a hospital environment for a long time. Research shows that people most at risk are those undergoing long-term broad-spectrum antibiotic treatments, which weaken the immune system and leave patients vulnerable to infectious diseases. Continue reading
Aspen University is dedicated to offering any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education for the purpose of achieving sustainable economic and social benefits for themselves and their families. Continue reading
Tuition under $10,000. Pay only $250 per month. 10 courses. 18 months. 100% Online.
RN to BSN Tuition Plan: Our goal is for our students to earn a high quality degree that will help them improve their career and income, without taking on large financial debt. There are two ways that we help our students achieve this goal. Continue reading
A study to examine the correlation of paired trends in hospital 30-day readmission rates and hospital 30-day mortality rates after discharge found that decreasing readmission rates did not result in decreased mortality. Read more at The JAMA Network.
Researchers develop method that could one day be used in brain trauma lawsuits
Lawyers representing both sides in concussion lawsuits against sports leagues may eventually have a new tool at their disposal: a diagnostic signature that uses artificial intelligence to detect brain trauma years after it has occurred.
While the short-term effects of head trauma can be devastating, the long-term effects can be equally hard for patients. The symptoms may linger years after the concussion happened. The problem is it is often hard to say whether their symptoms are being caused by a concussion or other factors like another neurological condition or the normal aging process. Continue reading
First approval for this rare blood disorder in nearly 20 years.
For Immediate Release: July 7, 2017 – via fda.gov
The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
“Endari is the first treatment approved for patients with sickle cell disease in almost 20 years,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the FDA’s Oncology Center of Excellence. “Until now, only one other drug was approved for patients living with this serious, debilitating condition.” Continue reading